↓ Skip to main content

Dove Medical Press

Empagliflozin in type 1 diabetes

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
34 Mendeley
Title
Empagliflozin in type 1 diabetes
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2019
DOI 10.2147/dmso.s194688
Pubmed ID
Authors

Chantal Mathieu, Laura Van Den Mooter, Bert Eeckhout

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 18%
Other 5 15%
Student > Master 5 15%
Student > Postgraduate 3 9%
Researcher 3 9%
Other 2 6%
Unknown 10 29%
Readers by discipline Count As %
Medicine and Dentistry 15 44%
Pharmacology, Toxicology and Pharmaceutical Science 4 12%
Biochemistry, Genetics and Molecular Biology 2 6%
Psychology 2 6%
Chemistry 1 3%
Other 0 0%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2023.
All research outputs
#14,457,469
of 25,663,438 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#402
of 1,195 outputs
Outputs of similar age
#169,046
of 360,353 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#15
of 46 outputs
Altmetric has tracked 25,663,438 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,195 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,353 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.